LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global immune checkpoint inhibitors market to grow at a CAGR of more than 19% during the forecast period, according to their latest market ...
NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results